This is further corroborated by the observation in prostate cancer cells, that the PI3K inhibitor LY294002, which stopped the migration and invasion of tumor cells, also caused the downregulation of LETM1 (Piao et al., 2020). This evidence concerns the gene LETM1 and neoplasm.